NanoVibronix (NAOV) Competitors

NanoVibronix (NASDAQ:NAOV) and TELA Bio (NASDAQ:TELA) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their community ranking, valuation, risk, institutional ownership, dividends, profitability, analyst recommendations, earnings and media sentiment.

Does the media prefer NAOV or TELA?

In the previous week, TELA Bio had 21 more articles in the media than NanoVibronix. MarketBeat recorded 25 mentions for TELA Bio and 4 mentions for NanoVibronix. NanoVibronix's average media sentiment score of 0.62 beat TELA Bio's score of 0.25 indicating that NanoVibronix is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
NanoVibronix	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
TELA Bio	3 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	7 Negative mention(s)	1 Very Negative mention(s)	Neutral

Does the MarketBeat Community prefer NAOV or TELA?

NanoVibronix received 11 more outperform votes than TELA Bio when rated by MarketBeat users. However, 74.07% of users gave TELA Bio an outperform vote while only 57.26% of users gave NanoVibronix an outperform vote.

Company	Underperform	Outperform
NanoVibronix	Outperform Votes 71 57.26%	Underperform Votes 53 42.74%
TELA Bio	Outperform Votes 60 74.07%	Underperform Votes 21 25.93%

Which has more volatility and risk, NAOV or TELA?

NanoVibronix has a beta of 1.81, indicating that its stock price is 81% more volatile than the S&P 500. Comparatively, TELA Bio has a beta of 1.1, indicating that its stock price is 10% more volatile than the S&P 500.

Do analysts rate NAOV or TELA?

TELA Bio has a consensus target price of $7.25, indicating a potential upside of 462.02%. Given TELA Bio's stronger consensus rating and higher possible upside, analysts plainly believe TELA Bio is more favorable than NanoVibronix.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NanoVibronix	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
TELA Bio	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75

Do institutionals & insiders have more ownership in NAOV or TELA?

16.4% of NanoVibronix shares are held by institutional investors. Comparatively, 94.3% of TELA Bio shares are held by institutional investors. 7.0% of NanoVibronix shares are held by company insiders. Comparatively, 6.0% of TELA Bio shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Which has stronger valuation and earnings, NAOV or TELA?

NanoVibronix has higher earnings, but lower revenue than TELA Bio. TELA Bio is trading at a lower price-to-earnings ratio than NanoVibronix, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NanoVibronix	$3.29M	0.93	-$3.71M	-$13.53	-0.29
TELA Bio	$69.30M	0.73	-$46.66M	-$1.39	-0.93

Is NAOV or TELA more profitable?

TELA Bio has a net margin of -60.49% compared to NanoVibronix's net margin of -93.80%. NanoVibronix's return on equity of -101.17% beat TELA Bio's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NanoVibronix	-93.80%	-101.17%	-53.03%
TELA Bio	-60.49%	-556.18%	-63.13%

Summary

TELA Bio beats NanoVibronix on 10 of the 18 factors compared between the two stocks.